Skip to main content

Viking Therapeutics stock jumps 15% on promising weight loss pill data

The Viking study results add to the growing excitement around the biotech company and its potential in the budding weight loss market.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.